Bio-Science Report, Christmas, FL 16 page color marketing mailer explains how “one tiny biotech company, CTBO, (CantaBio Pharmaceuticals previously Gardedam Pharmaceuticals), may have taken the lead in the all-out race for a cure for Alzheimer’s, Parkinson’s and Dementia… through multiple drug candidates, targeting the DJ-1 Protein”. Using selective compounds CB101 & CB102 and CB201. Dr. Gergely Toth, PhD Founder and CEO, of Gardedam, Palo Alto, CA in 2009, to present CEO of CantaBio plus consult with two neurodegenerative advisors all with affiliations to University of Cambridge. RECO: Buy up to $5.50.
Bio-Science Report, Christmas, FL 16 page color marketing mailer explains how “one tiny biotech company, CTBO, (CantaBio Pharmaceuticals previously Gardedam Pharmaceuticals), may have taken the lead in the all-out race for a cure for Alzheimer’s, Parkinson’s and Dementia… through multiple drug candidates, targeting the DJ-1 Protein”. Using selective compounds CB101 & CB102 and CB201.
Dr. Gergely Toth, PhD Founder and CEO, of Gardedam, Palo Alto, CA in 2009, to present CEO of CantaBio plus consult with two neurodegenerative advisors all with affiliations to University of Cambridge. RECO: Buy up to $5.50.